해외사업부

  • Non-Clinical Safty Assessment / DMPK & Bioanalysis

    • Non-Clinical Safety Assessment

      • General Toxicology
      • Safety Pharmacology
      • Developmental and Reproductive Toxicology
      • Juvenile Animal Study (JAS)
      • Genetic Toxicology
      • Carcinogenicity Studies
      • Ophthalmology Studies
      • Inhalation Studies
      • Drug Abuse & Substance Dependence
      • Immunogenicity and Immunotoxicity
      • Special Toxicities
      • Clinical Pathology
      • Toxicokinetics
      • Assessment of radiopharmaceuticals
      • Assessment of biohazardous drugs

    • DMPK and Bioanalysis

      • Test Article Formulation & Analysis
      • Method Development and GLP Bio-analysis Method Valideation
      • Drug-Drug Interactinons (DDI)
      • In Vitro ADME and In Vivo PK Study
      • Biomarker Identification
      • Element Residues
      • Immunology
      • Molecular Biology

  • Parmacology & Pharmacodynamics

    • 1) In Vitro Services

      • Immune cell typing
      • Flow cytometry
      • ELISPOT
      • Cytokine release

    • 2) In Vivo Models:

      • Tumors
      • Hematological Diseases
      • Cardiovascular Diseases
      • Neuropsychiatric Diseases
      • Respiratory Diseases
      • Metabolic Diseases
      • Urologic Diseases
      • Immunity Related Diseases
      • Digestive Diseases
      • Infectious Diseases
      • Others

  • Certificates & Qualification

    NMPA GLP Compliance 2005 / 2010 / 2013 / 2014 / 2017 / 2020
    US FDA GLP Compliance 2009 / 2013 / 2016 / 2019
    OECD GLP Compliance 2015 / 2017 / 2021
    Korean MFDS GLP Compliance 2016 / 2022
    Japan PMDA GLP Compliance 2021
    AAALAC accreditation 2008 / 2011 / 2014 / 2017 / 2020
    CNAS / ILAC-MRA certification 2018 / 2019 / 2020 / 2022